<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01951261</url>
  </required_header>
  <id_info>
    <org_study_id>TELEMEDCOPD</org_study_id>
    <nct_id>NCT01951261</nct_id>
  </id_info>
  <brief_title>Early Assisted Discharge for COPD Exacerbations With Telemonitoring.</brief_title>
  <official_title>Early Assisted Discharge With Generic Community Nursing and Pulmonary Physicians vs Telemonitoring at Home for Chronic Obstructive Pulmonary Disease Exacerbations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. López Viña</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Puerta de Hierro University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine if an early assisted discharge program for acute exacerbations of COPD (AECOPD),&#xD;
      with telemonitoring and telephone control, is equally effective and more efficient in terms&#xD;
      of use of health care resources, that a home care provided by hospital respiratory nurses and&#xD;
      pulmonologists.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study seeks to improve the health of patients with AECOPD by home care after discharge&#xD;
      from the Hospital using the technology of the information and the communication. The&#xD;
      investigators want evaluate the efficiency, satisfaction (patients, keepers) and&#xD;
      effectiveness of a program of early discharge with home care in patients with AECOPD with&#xD;
      telemonitoring and telephone control, in relation to the traditional protocol of home care&#xD;
      based on nurse and pulmonologist visits.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 2012</start_date>
  <completion_date type="Actual">December 2018</completion_date>
  <primary_completion_date type="Actual">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time Until the First Exacerbation</measure>
    <time_frame>Change from stable to exacerbation the first time at 6 month</time_frame>
    <description>Time until the first exacerbation is the time that patient is stable before a new exacerbation and meaning a good control of the disease.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>SATISFAD 10</measure>
    <time_frame>Participants will be followed for the duration home care, an expected average of 7 days</time_frame>
    <description>Instrument that evaluates satisfaction with home care services in a self-administered. The score ranges from 0 to 30, with the worst value being zero and the best value being 30.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>State-Trait Anxiety Inventory (STAI)</measure>
    <time_frame>Participants will be followed for the duration of home care, an expected average of 7 days</time_frame>
    <description>The structure of the scale resulting from the combination of item polarity dimensions and the original two factors (State and Trait Anxiety).&#xD;
Minimum value 0, maximum value 120. Lower score indicates higher anxiety.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Medication Adherence Assessed Using Morinsky-Green-Levine Test</measure>
    <time_frame>Participants will be followed for the duration of home care up 24 weeks</time_frame>
    <description>Consists of a series of 4 contrasting questions with answers dichotomous yes / no, reflecting the patient's behavior regarding compliance with medication. They are intended to assess whether the patient adopts correct attitudes regarding treatment for his illness; it is assumed that if attitudes they are incorrect the patient is non-compliant.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Monitoring Compliance</measure>
    <time_frame>Participants will be followed for the duration of home care, an expected average of 7 days</time_frame>
    <description>It represents the compliance of the patients with respect to the sending of constants through the telemedicine monitor that should be (following the protocol) at least twice a day. The patient was considered compliant if he sent the constant at least 2 twice a day or non-compliant otherwise.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Home Visits</measure>
    <time_frame>Participants will be followed for the duration of home care, an expected average of 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>COPD Assessment Test (CAT)</measure>
    <time_frame>Participants will be followed for the duration of home care and up to 4 weeks</time_frame>
    <description>It's a simple questionnaire for assessing and monitoring COPD. It quantifies chronic obstructive pulmonary disease (COPD) impact in routine practice to aid health status assessment.&#xD;
It's self-administered in 2 min. It consists of 8 items that measure aspects of cough, expectoration, chest tightness, dyspnea, domestic activities, self-confidence, sleep and energy. Each section is scored from 0 to 5 and therefore a maximum of 40 points can be obtained; a higher score indicates a greater negative impact of COPD. Significant clinical changes correspond to a variation of 2 points or more.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">116</enrollment>
  <condition>COPD Exacerbation</condition>
  <arm_group>
    <arm_group_label>telemonitoring and telephone control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Early discharge from hospital with telemonitoring, telephone control and three nurse scheduled visits.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>home care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Early discharge from hospital with home care provided by hospital respiratory nurses and pulmonologists (daily visits).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Telemonitoring and telephone control</intervention_name>
    <description>Early assisted discharge from hospital due to an exacerbation of chronic obstructive pulmonary disease, with telemonitoring of vitals signs (oxygen saturation, heart rate, respiratory rate, blood pressure, temperature and electrocardiogram)and telephone control dairy (morning, evening)by the pulmonologist.</description>
    <arm_group_label>telemonitoring and telephone control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients admitted to the hospital with COPD exacerbation&#xD;
&#xD;
          -  No concomitant serious unstable diseases&#xD;
&#xD;
          -  Without fever in 48 hours&#xD;
&#xD;
          -  Aerosol treatment at the most every 6 hours&#xD;
&#xD;
          -  Treatment with glucocorticoid intravenous &lt; 40 mg twice a day&#xD;
&#xD;
          -  A thoracic radiograph without new disease&#xD;
&#xD;
          -  Subjective improvement of the patient&#xD;
&#xD;
          -  Familiar suitable environment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Neoplasias and other chronic diseases in terminal situation&#xD;
&#xD;
          -  Alcoholism&#xD;
&#xD;
          -  Intravenous medication&#xD;
&#xD;
          -  Disability to understand and take part in the program&#xD;
&#xD;
          -  Admitted to intensive care unit (ICU) or non invasive mechanical ventilation during&#xD;
             the exacerbation&#xD;
&#xD;
          -  Unstability hemodynamic&#xD;
&#xD;
          -  To be an institutionalized patient.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antolín Lopez Viña, physician</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Puerta de Hierro</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antolín Lopez Viña, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Puerta de Hierro</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitary Hospital Puerta de Hierro.</name>
      <address>
        <city>Majadahonda</city>
        <state>Madrid</state>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 3, 2013</study_first_submitted>
  <study_first_submitted_qc>September 23, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2013</study_first_posted>
  <results_first_submitted>June 13, 2020</results_first_submitted>
  <results_first_submitted_qc>September 19, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">October 14, 2020</results_first_posted>
  <last_update_submitted>September 19, 2020</last_update_submitted>
  <last_update_submitted_qc>September 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Puerta de Hierro University Hospital</investigator_affiliation>
    <investigator_full_name>Dr. López Viña</investigator_full_name>
    <investigator_title>Investigator</investigator_title>
  </responsible_party>
  <keyword>Telemonitoring</keyword>
  <keyword>COPD</keyword>
  <keyword>Home care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Share All of the individual participant data collected during the trial, after identification.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Immediately following publication. No end date.</ipd_time_frame>
    <ipd_access_criteria>Proposals should be directed to drapat1@yahoo.es. To gain access, data requestors will need to sign a data access agreement.</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 1, 2012</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/61/NCT01951261/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 1, 2012</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/61/NCT01951261/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Telemonitoring and Telephone Control</title>
          <description>Early discharge from hospital with telemonitoring, telephone control and three nurse scheduled visits.&#xD;
Telemonitoring and telephone control: Early assisted discharge from hospital due to an exacerbation of chronic obstructive pulmonary disease, with telemonitoring of vitals signs (oxygen saturation, heart rate, respiratory rate, blood pressure, temperature and electrocardiogram)and telephone control dairy (morning, evening)by the pulmonologist.</description>
        </group>
        <group group_id="P2">
          <title>Home Care</title>
          <description>Early discharge from hospital with home care provided by hospital respiratory nurses and pulmonologists (dairy visits).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="58"/>
                <participants group_id="P2" count="58"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Discontinued</title>
              <participants_list>
                <participants group_id="P1" count="9">2-readmission when was at home&#xD;
1-monitor failure&#xD;
1-new home hospitalitation 4-missing&#xD;
1-death</participants>
                <participants group_id="P2" count="6">2-readmission when was at home&#xD;
1-new home hospitalitation 3-missing</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="49"/>
                <participants group_id="P2" count="52"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Telemonitoring and Telephone Control</title>
          <description>Early discharge from hospital with telemonitoring, telephone control and three nurse scheduled visits.&#xD;
Telemonitoring and telephone control: Early assisted discharge from hospital due to an exacerbation of chronic obstructive pulmonary disease, with telemonitoring of vitals signs (oxygen saturation, heart rate, respiratory rate, blood pressure, temperature and electrocardiogram)and telephone control dairy (morning, evening)by the pulmonologist.</description>
        </group>
        <group group_id="B2">
          <title>Home Care</title>
          <description>Early discharge from hospital with home care provided by hospital respiratory nurses and pulmonologists (dairy visits).</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="58"/>
            <count group_id="B2" value="58"/>
            <count group_id="B3" value="116"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="58"/>
                    <count group_id="B2" value="58"/>
                    <count group_id="B3" value="116"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68" spread="8"/>
                    <measurement group_id="B2" value="70" spread="8"/>
                    <measurement group_id="B3" value="69" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="58"/>
                    <count group_id="B2" value="58"/>
                    <count group_id="B3" value="116"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="36"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body mass index (BMI) (Mean (Standard Deviation)</title>
          <units>Kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="58"/>
                    <count group_id="B2" value="58"/>
                    <count group_id="B3" value="116"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.1" spread="4"/>
                    <measurement group_id="B2" value="26.5" spread="4"/>
                    <measurement group_id="B3" value="26.8" spread="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time Until the First Exacerbation</title>
        <description>Time until the first exacerbation is the time that patient is stable before a new exacerbation and meaning a good control of the disease.</description>
        <time_frame>Change from stable to exacerbation the first time at 6 month</time_frame>
        <population>The overall number of participants analyzed is not consistent with numbers provided in any of the rows in the participant flow module, because in the telemedicine group and the home care group, patients who readmission were not included, nor was the patient in whom the monitor did not work.</population>
        <group_list>
          <group group_id="O1">
            <title>Telemonitoring and Telephone Control</title>
            <description>Early discharge from hospital with telemonitoring, telephone control and three nurse scheduled visits.&#xD;
Telemonitoring and telephone control: Early assisted discharge from hospital due to an exacerbation of chronic obstructive pulmonary disease, with telemonitoring of vitals signs (oxygen saturation, heart rate, respiratory rate, blood pressure, temperature and electrocardiogram)and telephone control dairy (morning, evening)by the pulmonologist.</description>
          </group>
          <group group_id="O2">
            <title>Home Care</title>
            <description>Early discharge from hospital with home care provided by hospital respiratory nurses and pulmonologists (dairy visits).</description>
          </group>
        </group_list>
        <measure>
          <title>Time Until the First Exacerbation</title>
          <description>Time until the first exacerbation is the time that patient is stable before a new exacerbation and meaning a good control of the disease.</description>
          <population>The overall number of participants analyzed is not consistent with numbers provided in any of the rows in the participant flow module, because in the telemedicine group and the home care group, patients who readmission were not included, nor was the patient in whom the monitor did not work.</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47" lower_limit="19" upper_limit="102"/>
                    <measurement group_id="O2" value="48" lower_limit="23" upper_limit="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>sample size calculation was made, considering it appropriate to set a limit of non-inferiority with respect to the main variable of 1.2 months (36 days), the study being lower if it will have exacerbation before this period of time, with a follow-up of 6 months, It was required to include a sample of 58 patients per group for a potency of 80% and a significance level of 5%.</non_inferiority_desc>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>The reported p-value was calculated.Statistical analysis of the main variable was performed using the Kaplan-Meier method and log-rank test</p_value_desc>
            <method>Log Rank</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>SATISFAD 10</title>
        <description>Instrument that evaluates satisfaction with home care services in a self-administered. The score ranges from 0 to 30, with the worst value being zero and the best value being 30.</description>
        <time_frame>Participants will be followed for the duration home care, an expected average of 7 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Telemonitoring and Telephone Control</title>
            <description>Early discharge from hospital with telemonitoring, telephone control and three nurse scheduled visits.&#xD;
Telemonitoring and telephone control: Early assisted discharge from hospital due to an exacerbation of chronic obstructive pulmonary disease, with telemonitoring of vitals signs (oxygen saturation, heart rate, respiratory rate, blood pressure, temperature and electrocardiogram)and telephone control dairy (morning, evening)by the pulmonologist.</description>
          </group>
          <group group_id="O2">
            <title>Home Care</title>
            <description>Early discharge from hospital with home care provided by hospital respiratory nurses and pulmonologists (dairy visits).</description>
          </group>
        </group_list>
        <measure>
          <title>SATISFAD 10</title>
          <description>Instrument that evaluates satisfaction with home care services in a self-administered. The score ranges from 0 to 30, with the worst value being zero and the best value being 30.</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30" lower_limit="29" upper_limit="30"/>
                    <measurement group_id="O2" value="30" lower_limit="27" upper_limit="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>State-Trait Anxiety Inventory (STAI)</title>
        <description>The structure of the scale resulting from the combination of item polarity dimensions and the original two factors (State and Trait Anxiety).&#xD;
Minimum value 0, maximum value 120. Lower score indicates higher anxiety.</description>
        <time_frame>Participants will be followed for the duration of home care, an expected average of 7 days</time_frame>
        <population>Not all study participants completed the test, so it does not correspond to the number of the flow chart.</population>
        <group_list>
          <group group_id="O1">
            <title>Telemonitoring and Telephone Control</title>
            <description>Early discharge from hospital with telemonitoring, telephone control and three nurse scheduled visits.&#xD;
Telemonitoring and telephone control: Early assisted discharge from hospital due to an exacerbation of chronic obstructive pulmonary disease, with telemonitoring of vitals signs (oxygen saturation, heart rate, respiratory rate, blood pressure, temperature and electrocardiogram)and telephone control dairy (morning, evening)by the pulmonologist.</description>
          </group>
          <group group_id="O2">
            <title>Home Care</title>
            <description>Early discharge from hospital with home care provided by hospital respiratory nurses and pulmonologists (dairy visits).</description>
          </group>
        </group_list>
        <measure>
          <title>State-Trait Anxiety Inventory (STAI)</title>
          <description>The structure of the scale resulting from the combination of item polarity dimensions and the original two factors (State and Trait Anxiety).&#xD;
Minimum value 0, maximum value 120. Lower score indicates higher anxiety.</description>
          <population>Not all study participants completed the test, so it does not correspond to the number of the flow chart.</population>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>State</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15" lower_limit="10" upper_limit="26"/>
                    <measurement group_id="O2" value="17" lower_limit="12" upper_limit="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Trait</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20" lower_limit="15" upper_limit="26"/>
                    <measurement group_id="O2" value="23" lower_limit="17" upper_limit="27.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Medication Adherence Assessed Using Morinsky-Green-Levine Test</title>
        <description>Consists of a series of 4 contrasting questions with answers dichotomous yes / no, reflecting the patient's behavior regarding compliance with medication. They are intended to assess whether the patient adopts correct attitudes regarding treatment for his illness; it is assumed that if attitudes they are incorrect the patient is non-compliant.</description>
        <time_frame>Participants will be followed for the duration of home care up 24 weeks</time_frame>
        <population>Not all study participants completed the test, so it does not correspond to the number of the flow chart.</population>
        <group_list>
          <group group_id="O1">
            <title>Telemonitoring and Telephone Control</title>
            <description>Early discharge from hospital with telemonitoring, telephone control and three nurse scheduled visits.&#xD;
Telemonitoring and telephone control: Early assisted discharge from hospital due to an exacerbation of chronic obstructive pulmonary disease, with telemonitoring of vitals signs (oxygen saturation, heart rate, respiratory rate, blood pressure, temperature and electrocardiogram)and telephone control dairy (morning, evening)by the pulmonologist.</description>
          </group>
          <group group_id="O2">
            <title>Home Care</title>
            <description>Early discharge from hospital with home care provided by hospital respiratory nurses and pulmonologists (dairy visits).</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Medication Adherence Assessed Using Morinsky-Green-Levine Test</title>
          <description>Consists of a series of 4 contrasting questions with answers dichotomous yes / no, reflecting the patient's behavior regarding compliance with medication. They are intended to assess whether the patient adopts correct attitudes regarding treatment for his illness; it is assumed that if attitudes they are incorrect the patient is non-compliant.</description>
          <population>Not all study participants completed the test, so it does not correspond to the number of the flow chart.</population>
          <units>percentage of adherents</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Initial</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77"/>
                    <measurement group_id="O2" value="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At 6 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86"/>
                    <measurement group_id="O2" value="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Monitoring Compliance</title>
        <description>It represents the compliance of the patients with respect to the sending of constants through the telemedicine monitor that should be (following the protocol) at least twice a day. The patient was considered compliant if he sent the constant at least 2 twice a day or non-compliant otherwise.</description>
        <time_frame>Participants will be followed for the duration of home care, an expected average of 7 days</time_frame>
        <population>In the home care group, patients did not send constants. Data from 55 patients were analyzed (2 readmissions and one patient in which the monitor failed were not included in the analysis)</population>
        <group_list>
          <group group_id="O1">
            <title>Telemonitoring and Telephone Control</title>
            <description>Early discharge from hospital with telemonitoring, telephone control and three nurse scheduled visits.&#xD;
Telemonitoring and telephone control: Early assisted discharge from hospital due to an exacerbation of chronic obstructive pulmonary disease, with telemonitoring of vitals signs (oxygen saturation, heart rate, respiratory rate, blood pressure, temperature and electrocardiogram)and telephone control dairy (morning, evening)by the pulmonologist.</description>
          </group>
          <group group_id="O2">
            <title>Home Care</title>
            <description>Early discharge from hospital with home care provided by hospital respiratory nurses and pulmonologists (dairy visits).</description>
          </group>
        </group_list>
        <measure>
          <title>Monitoring Compliance</title>
          <description>It represents the compliance of the patients with respect to the sending of constants through the telemedicine monitor that should be (following the protocol) at least twice a day. The patient was considered compliant if he sent the constant at least 2 twice a day or non-compliant otherwise.</description>
          <population>In the home care group, patients did not send constants. Data from 55 patients were analyzed (2 readmissions and one patient in which the monitor failed were not included in the analysis)</population>
          <units>sending of constant</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="55"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.23" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Home Visits</title>
        <time_frame>Participants will be followed for the duration of home care, an expected average of 7 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Telemonitoring and Telephone Control</title>
            <description>Early discharge from hospital with telemonitoring, telephone control and three nurse scheduled visits.&#xD;
Telemonitoring and telephone control: Early assisted discharge from hospital due to an exacerbation of chronic obstructive pulmonary disease, with telemonitoring of vitals signs (oxygen saturation, heart rate, respiratory rate, blood pressure, temperature and electrocardiogram)and telephone control dairy (morning, evening)by the pulmonologist.</description>
          </group>
          <group group_id="O2">
            <title>Home Care</title>
            <description>Early discharge from hospital with home care provided by hospital respiratory nurses and pulmonologists (dairy visits).</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Home Visits</title>
          <units>visits</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="57"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8" spread="1"/>
                    <measurement group_id="O2" value="5.1" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>COPD Assessment Test (CAT)</title>
        <description>It's a simple questionnaire for assessing and monitoring COPD. It quantifies chronic obstructive pulmonary disease (COPD) impact in routine practice to aid health status assessment.&#xD;
It's self-administered in 2 min. It consists of 8 items that measure aspects of cough, expectoration, chest tightness, dyspnea, domestic activities, self-confidence, sleep and energy. Each section is scored from 0 to 5 and therefore a maximum of 40 points can be obtained; a higher score indicates a greater negative impact of COPD. Significant clinical changes correspond to a variation of 2 points or more.</description>
        <time_frame>Participants will be followed for the duration of home care and up to 4 weeks</time_frame>
        <population>Not all study participants completed the test, so it does not correspond to the number of the flow chart.</population>
        <group_list>
          <group group_id="O1">
            <title>Telemonitoring and Telephone Control</title>
            <description>Early discharge from hospital with telemonitoring, telephone control and three nurse scheduled visits.&#xD;
Telemonitoring and telephone control: Early assisted discharge from hospital due to an exacerbation of chronic obstructive pulmonary disease, with telemonitoring of vitals signs (oxygen saturation, heart rate, respiratory rate, blood pressure, temperature and electrocardiogram)and telephone control dairy (morning, evening)by the pulmonologist.</description>
          </group>
          <group group_id="O2">
            <title>Home Care</title>
            <description>Early discharge from hospital with home care provided by hospital respiratory nurses and pulmonologists (dairy visits).</description>
          </group>
        </group_list>
        <measure>
          <title>COPD Assessment Test (CAT)</title>
          <description>It's a simple questionnaire for assessing and monitoring COPD. It quantifies chronic obstructive pulmonary disease (COPD) impact in routine practice to aid health status assessment.&#xD;
It's self-administered in 2 min. It consists of 8 items that measure aspects of cough, expectoration, chest tightness, dyspnea, domestic activities, self-confidence, sleep and energy. Each section is scored from 0 to 5 and therefore a maximum of 40 points can be obtained; a higher score indicates a greater negative impact of COPD. Significant clinical changes correspond to a variation of 2 points or more.</description>
          <population>Not all study participants completed the test, so it does not correspond to the number of the flow chart.</population>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Initial</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" lower_limit="7" upper_limit="15"/>
                    <measurement group_id="O2" value="15" lower_limit="9" upper_limit="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At first month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" lower_limit="5" upper_limit="15"/>
                    <measurement group_id="O2" value="8" lower_limit="4.5" upper_limit="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>During home follow-up until 6 months after the discharge.</time_frame>
      <desc>All adverse events caused the patient to be hospitalized.</desc>
      <group_list>
        <group group_id="E1">
          <title>Telemonitoring and Telephone Control</title>
          <description>Early discharge from hospital with telemonitoring, telephone control and three nurse scheduled visits.&#xD;
Telemonitoring and telephone control: Early assisted discharge from hospital due to an exacerbation of chronic obstructive pulmonary disease, with telemonitoring of vitals signs (oxygen saturation, heart rate, respiratory rate, blood pressure, temperature and electrocardiogram)and telephone control dairy (morning, evening)by the pulmonologist.</description>
        </group>
        <group group_id="E2">
          <title>Home Care</title>
          <description>Early discharge from hospital with home care provided by hospital respiratory nurses and pulmonologists (dairy visits).</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="58"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="58"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="58"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>rapid atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="58"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>pain secondary to vertebral crushing</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="58"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="58"/>
              </event>
              <event>
                <sub_title>necrotizing pneumonia.</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="58"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="58"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dra Patricia Mínguez Clemente</name_or_title>
      <organization>Hospital Puerta de Hierro</organization>
      <phone>911916859</phone>
      <email>drapat3@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

